A Phase 1 interventional study of Ketone monoester and Placebo in Ketones and Dietary Supplements, sponsored by University of British Columbia. Completed at 1 site in Canada. Open to participants aged 30 Years to 65 Years. Per ClinicalTrials.gov, last updated 2019-04-18.
Sponsored by University of British Columbia · Phase 1, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 11 studies testing (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in Ketosis — 3 open to participants now, 3 under way, none of them phase 3. (R)-3-hydroxybutyl (R)-3-hydroxybutyrate · Ketosis.
Among the 11 studies testing (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in Ketosis, this one is the 7th largest by enrollment, is the only one that started in 2018, is the only one in phase 1, and was the 1st registered.
218 studies on the registry are indexed under Ketosis; 50 are open to participants now.
Browse Ketosis studies →3 of the 11 studies testing (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in Ketosis are open now, in 3 countries. Recruiting first, the newest first:
Vanderbilt University Medical Center · Sites in United States
Ages 18+
Institute for Clinical and Experimental Medicine · Sites in Czechia
Ages 18+
University of British Columbia · Sites in Canada
Ages 19+ · Healthy volunteers
By country, each count listing its studies:
No approval found in the FDA or EMA files read. How studies give it is on its page →
Of the 30 Ketosis studies recruiting now, 6 (20%) set no upper age limit and 22 (73%) stop at 75 or younger; 1 takes children under 18; 8 take healthy volunteers.
This study: 30 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
11 studies; the count open now beside each. This study's row is marked.
First in 2018; this study’s year is marked. 1 started in 2018.
This study's enrollment of 15 is below the median of 20 across 190 interventional studies indexed under Ketosis.
Median enrollment 16 across the 11 interventional studies. Of the 7 that completed or were terminated, 2 (29%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 11 has an industry lead sponsor. The 8 most frequent:
University of British Columbia is the lead sponsor of 1,340 studies on the registry; 260 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.
12 studies in Ketosis by University of British Columbia: 2 open now, 4 under way, none of them phase 3. Of 8 finished, 2 (25%) have results posted.
Among the 12 studies in Ketosis by University of British Columbia, this one is the 6th largest by enrollment, is the only one that started in 2018, is the only one in phase 1, and was the 3rd registered.
University of British Columbia’s Ketosis studies by the year they started, since 2016.
2 of the studies testing (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in Ketosis that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07364162Vanderbilt University Medical CenterExogenous Ketone Supplementation in ICU Delirium | 2026-12-31 |
| NCT07527156Institute for Clinical and Experimental MedicineProlonged Nasogastric Administration of Ketones in Decompensated Heart Failure | 2027-03-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 11 studies testing (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in Ketosis, from their registry updates:
Nothing recorded among them since 2026-09-25.
Among University of British Columbia’s 12 in Ketosis:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The ketone body beta-hydroxybutyrate is produced during prolonged fasting or when endogenous carbohydrate stores are depleted and can be used as an alternative fuel source. Exogenous beta-hydroxybutyrate, in the form of a ketone monoester, is proposed to have glucose-lowering potential but this has not been adequately studied. The purpose of this study is to determine whether supplementing with an acute dose of ketone monoester can improve the glycemic response to an oral glucose tolerance test in individuals with impaired fasting glucose.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Acute morning dose of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate (0.45 ml/kg body weight)
Dietary Supplement: Ketone monoester
Acute morning dose of flavour-matched placebo.
Dietary Supplement: Placebo
Acute ingestion of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate prior a 2-hour oral glucose tolerance test.
Acute ingestion of a taste-matched placebo prior a 2-hour oral glucose tolerance test.
Glucose area under the curve
Area under the curve for glucose during oral glucose tolerance test
Time frame: 2-hour
Insulin area under the curve
Insulin area under the curve during oral glucose tolerance test
Time frame: 2-hour
Free fatty acids area under the curve
Non-esterified fatty acids area under the curve during oral glucose tolerance test
Time frame: 2-hour
Caspase-1 activation
Caspase-1 activation assessed before and after ketone or placebo ingestion in the morning
Time frame: 15 minutes
Inflammatory cytokines
Inflammatory cytokines assessed before and after ketone or placebo ingestion in the morning
Time frame: 15 minutes
C-peptide area under the curve
C-peptide area under the curve during oral glucose tolerance test
Time frame: 2-hour
GLP-1 area under the curve
GLP-1 area under the curve during oral glucose tolerance test
Time frame: 2-hour
Glucagon area under the curve
Glucagon area under the curve during oral glucose tolerance test
Time frame: 2-hour
Glucose incremental area under the curve
Incremental area under the curve (above baseline) for glucose during oral glucose tolerance test
Time frame: 2-hour
Insulin incremental area under the curve
Incremental area under the curve (above baseline) for insulin during oral glucose tolerance test
Time frame: 2-hour
2-hr glucose level
Plasma glucose assessed 2-hr after oral glucose tolerance test.
Time frame: 2-hour
Oral glucose sensitivity index
Oral glucose sensitivity index derived from glucose and insulin values throughout the 2-hr oral glucose tolerance test
Time frame: 2-hour
Plan to share: No
Ran from Mar 2018 to primary completion in Oct 2018, 6 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: (R)-3-hydroxybutyl (R)-3-hydroxybutyrate
University of British Columbia →